BioCryst Pharmaceuticals, Inc.
BCRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $13 | $5 | $0 | -$27 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $21 | $21 | $21 |
| Change in WC | -$1 | $2 | -$62 | -$11 |
| Other Non-Cash | $29 | $12 | $13 | $11 |
| Operating Cash Flow | $41 | $41 | -$28 | -$5 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$59 | -$29 | -$49 | -$40 |
| Inv. Sales/Matur. | $73 | $59 | $76 | $58 |
| Other Inv. Act. | $1 | $0 | $0 | $0 |
| Investing Cash Flow | $14 | $29 | $27 | $18 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$60 | -$70 | -$1 | -$0 |
| Stock Issued | $3 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$4 | $1 | -$4 |
| Financing Cash Flow | -$58 | -$74 | $1 | -$4 |
| Forex Effect | -$0 | -$14 | $0 | -$1 |
| Net Chg. in Cash | -$4 | -$17 | $1 | $7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $89 | $107 | $106 | $99 |
| End Cash | $85 | $90 | $107 | $106 |
| Free Cash Flow | $40 | $41 | -$28 | -$6 |